Atlas Trials

QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa

Clinical trial NCT07417917 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07417917
Sponsor
Qilu Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Adults With Moderate-to-severe Hidradenitis Suppurativa
Start date
2026-04-01
Primary completion
2027-06-01
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.